[This review was originally posted at the Nieman Journalism Lab Flagyl No Rx, on July 8, 2011.]
Google's biggest social effort yet: This is a two-week edition of This Week in Review, so most of our news comes from last week, rather than this week. The biggest of those stories was the launch of Google+, Google's latest and most substantial foray into the social media landscape. TechCrunch had one of the first and best explanations of what Google+ is all about, and Wired's Steven Levy wrote the most comprehensive account of the thinking at Google behind Plus: It's the product of a fundamental philosophical shift from the web as information to the web as people.
Of course, the force to be reckoned with in any big social media venture is Facebook, and even though Google told Search Engine Land it's not made to be a Facebook competitor, Flagyl pics, Google+ was seen by many (including the New York Times) as Google's most ambitious attempt yet to take on Facebook. The design looks a lot like Facebook, and pages for businesses (like Facebook's Fan Pages) are on their way.
Longtime tech blogger Dave Winer was unimpressed at the effort to challenge Facebook, and Om Malik of GigaOM said Facebook has nothing to be afraid of in Google+, though All Facebook's Nick O'Neill said Google+'s ubiquity across the web should present a threat to Facebook, Flagyl No Rx.
But the biggest contrast people drew between Google+ and Facebook was the more intuitive privacy controls built into its Circles feature. Ex-Salon editor Scott Rosenberg wrote a particularly thoughtful post arguing that Google+ more accurately reflects social life than Facebook: "In truth, Facebook started out with an oversimplified conception of social life, Order Flagyl online overnight delivery no prescription, modeled on the artificial hothouse community of a college campus, and it has never succeeded in providing a usable or convenient method for dividing or organizing your life into its different contexts." His thought was echoed by j-prof Jeremy Littau (in two posts) and the Guardian's Dan Gillmor.
Google's other ventures into social media — Buzz, Wave, Orkut — have fallen flat, so it's somewhat surprising to see that the initial reviews for Google+ were generally positive. Among those enamored with it were TechCrunch's MG Siegler, ReadWriteWeb's Marshall Kirkpatrick, Flagyl schedule, social media guru Robert Scoble, and the Huffington Post's Craig Kanalley (though he wondered about Google's timing). It quickly began sending TechCrunch loads of traffic Flagyl No Rx, , and social media marketer Chris Brogan brainstormed 50 ways Google+ could influence the rest of the web.
At the same time, there was some skepticism about its Circles function: TechCrunch's Siegler wondered whether people would use it as intended, and ReadWriteWeb's Sarah Perez said they might not be equipped to handle complicated, changing relationships. Flagyl over the counter, GigaOM's Mathew Ingram, meanwhile, said Circles look great, but they aren't going to be much use until there's a critical mass of people to put in them.
—
Google+ and the news: This being a journalism blog, we're most interested in Google+ for what it means for news. As Poynter's Jeff Sonderman pointed out, the aspect of Google+ that seems to have the most potential is its Sparks feature, Flagyl samples, which allows users to collect recommended news around a specific term or phrase. Former New York Times reporter Jennifer 8, Flagyl No Rx. Lee said Sparks could fill a valuable niche for news organizations in between Facebook and Twitter — sort of a more customizable, less awkward RSS. The University of Missouri’s KOMU-TV has already used it in a live broadcast, and Breaking News’ Cory Bergman gave a few valuable lessons from that organization’s first week on Google+.
CUNY j-prof Jeff Jarvis gave his thoughts on a few potential uses for news: It could be very useful for collaboration and promotion, Flagyl alternatives, but not so much for live coverage. Journalism.co.uk's Sarah Marshall listed several of the same uses, plus interviewing and "as a Facebook for your tweeps." Sonderman suggested a few changes to Google+ to make it even more news-friendly, including allowing news org pages and improving the Sparks search and filtering. Flagyl No Rx, Still, he saw it as a valuable addition to the online news consumption landscape: "It’s a serendipity engine, and if executed well it could make Google+ an addictive source of news discovery."
A bit of Google+-related miscellany before we move on: Social media marketer Christopher Penn gave some tips on measuring Google+, author Neil Strauss condemned the growing culture of Facebook "Likes" (and now Google +1s), and GigaOM's Mathew Ingram offered a rebuttal.
—
Murdoch kills News of the World: In one of the most surprising media-related moves of the year, Rupert Murdoch's News Corp. suddenly shut down one of its most prominent properties, the 168-year-old British tabloid News of the World, buy Flagyl online no prescription, on Thursday. The decision stemmed from a long-running scandal involving NotW investigators who illegally hacked into the phones of celebrities. This week, the Guardian reported that the hacking extended to the voicemail of a murdered 13-year-old girl and possibly the families of dead soldiers, and that the paper's editor, Rebekah Brooks (now the head of News Corp. in Britain) was informed of some of the hacking, Flagyl No Rx. Buy generic Flagyl, Facing an advertising boycott and Parliamentary opposition, Murdoch's son, James, announced News of the World will close this weekend. (The Guardian has the definitive blow-by-blow of Thursday's events.) It was a desperate move, and as the New York Times, paidContent, and many on Twitter noted, order Flagyl from mexican pharmacy, it was almost certainly an attempt to keep the scandal's collateral damage away from Murdoch's proposed BSkyB merger, which was put on hold and possible in jeopardy this week.
Though the closing left hundreds of suddenly out-of-work employees, it may prove less damaging in the big picture for News Corp. than you might expect. Flagyl No Rx, NotW only published on Sundays, and it's widely suspected that its sister tabloid, the Sun, will simply expand to include a Sunday edition to cover for its absence. As one Guardian editor stated, Real brand Flagyl online, the move may simply allow News Corp. to streamline its operation and save cash, and Poynter’s Rick Edmonds called it a smart business move. (Its stock actually went up after the announcement.)
There's plenty that has yet to play out: The Guardian pointed out how evasive James Murdoch's closing letter was, and Brooks, the one that many thought would take the fall for the scandal, is still around. And the investigation is ongoing, with more arrests being made today, fast shipping Flagyl. According to the New Yorker's Ken Auletta and CUNY's Jeff Jarvis, though, the buck stops with Rupert himself and the culture he created.
—
Making journalism easier on Twitter: Twitter has been reaching out to journalists for quite some time now through a media blog, but last week it took things a step further and launched Twitter for Newsrooms, a journalist's guide to using Twitter, with tips on reporting, making conversation, and promoting content, Flagyl No Rx. The Lab's Justin Ellis gave a quick glimpse into the rationale behind the project.
A few people were skeptical: TechCrunch's Alexia Tsotsis suspected that Twitter's preaching to the choir, arguing that for the journalists who come across Twitter for Newsrooms, Flagyl photos, Twitter already is a newsroom. The Journal Register's Steve Buttry called it "more promotional than helpful," and suggested some other Twitter primers for journalists. Ad Age's Matthew Creamer added a tongue-in-cheek guide to releasing your anger on Twitter. Flagyl No Rx, Meanwhile, the Lab's Megan Garber reported on the ideas of NPR and Andy Carvin for improving Twitter's functionality for reporting, including a kind of real-time influence and credibility score for Twitter sources, and a journalism-oriented meme-tracking tool for developing stories.
—
Mobile media and tablet users, profiled: There were several studies released in the past two weeks that are worth noting, starting with Pew's report on e-reader and tablet users. Pew found that e-reader ownership is booming, Flagyl use, having doubled in six months. The Knight Digital Media Center's Amy Gahran reasoned that e-readers are ahead of tablets right now primarily because they're so much cheaper, and offered ideas for news organizations to take advantage of the explosion of e-reader users.
Three other studies related to tablets and mobile media: One study found that a third of tablet users said it's leading them to read print newspapers and magazines less often; another showed that people are reading more on digital media than we think, and mostly in browsers; and a third gave us more evidence that games are still king among mobile apps.
—
Reading roundup: Bunches of good stuff to look through from the past two weeks, Flagyl No Rx. I'll go through it quickly:
— Turns out the "digital first" move announced last month by the Guardian also includes the closing of the international editions of the Guardian and Observer. Flagyl for sale, Jeff Jarvis explained what digital first means, but Suw Charman-Anderson questioned the wisdom the Guardian's strategy. The Lab's Ken Doctor analyzed the economics of the Guardian's situation, as well as the Mail and the BBC's.
— This week in AOL/Huffington Post news: Business Insider revealed some leaked lackluster traffic numbers for Patch sites, and reported that Patch is undergoing a HuffPo-ization. That prompted Judy Sims and Slate's Jack Shafer Flagyl No Rx, to be the latest to rip into Patch's business model, and Shafer followed up to address rebuttals about non-Patch hyperlocal news.
— Google+ was the only interesting Google-related news over the past two weeks: The Lab's Megan Garber wrote about Google's bid to transform mobile ads, potential new directions for Google News, online buy Flagyl without a prescription, and Google highlighting individual authors in search returns. The New York Times' Virginia Heffernan also wrote on Google's ongoing war on "nonsense" content.
— A couple of paywall notes: The Times of London reported that it has 100,000 subscribers a year after its paywall went up, and Dorian Benkoil said the New York Times' plan is working well, the Lab's Megan Garber wrote about the Times adding a "share your access" offer to print subscribers.
— Three practical posts for journalists: Poynter's Jeff Sonderman has tips for successful news aggregation and personalized news delivery, and British j-prof Paul Bradshaw reported on his experience running his blog through a Facebook Page for a month.
— And three bigger-picture pieces to think on: Wetpaint's Ben Elowitz on the shrinking of the non-Facebook web, former Guardian digital editor Emily Bell on the U.S.' place within the global media ecosystem, and the Economist on the role of news organizations in a citizen-driven media world.
Similar posts: Purchase Cipro. Diflucan No Rx. Buy Lipitor No Prescription. Retin A samples. Order Synthroid no prescription. Discount Lipitor.
Trackbacks from: Flagyl No Rx. Flagyl No Rx. Flagyl No Rx. Flagyl coupon. What is Flagyl. Is Flagyl safe.
[This review was originally posted at the Nieman Journalism Lab Glucophage Mg, on Oct. 15, 2010.]
Advances for paid content on the iPad: We start this week with a whole bunch of data points regarding journalism and mobile devices; I'll try to tie them together for you the best I can. Conde Nast, one of the world's largest magazine publishers, has done the most thorough iPad research we've seen so far, with more than 100 hours of in-person interviews and in-app surveys with more than 5, Glucophage used for, 000 respondents. Conde Nast released some of its findings this week, which included five pieces of advice for mobile advertisers that were heavy on interactivity and clear navigation. They also discovered some good news for mobile advertisers: The iPad's early users aren't simply the typical tech-geek early adopter set, and about four-fifths of them were happy with their experiences with Conde Nast's apps.
MocoNews had the most detailed look at Conde Nast's study, arguing that the fact that iPads are shared extensively means they're not being treated as a mobile device, buy generic Glucophage. Users also seemed to spend much more time with the mobile versions of the magazines than the print versions, though that data's a little cloudy, Glucophage Mg. NPR has also done some research on its users via Twitter and Facebook, and the Lab's Justin Ellis reported that they've found that those listeners are generally younger, hardcore listeners. Together, Facebook and Twitter account for 7 to 8 percent of NPR's web traffic, Online buying Glucophage, though Facebook generates six times as much as Twitter.
There were also a few items on newspapers and the iPad: Forbes' Jeff Bercovici reported that the New York Post will become the first newspaper without a paid website to start selling an iPad app subscription. The subscription is only sold inside the app, a strategy that The Next Web's Martin Bryant called a psychological trick that "makes users feel less like they’re paying for news and more like they’re 'Just buying another app.'" The British newspaper The Financial Times said its iPad app has made about £1 million in advertising revenue since it was launched in May, but as Poynter's Damon Kiesow noted, local papers have been slow to jump on the iPad train, with only a dozen of launching apps so far, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release. Glucophage Mg, Meanwhile, GigaOM's Mathew Ingram ripped most magazine iPad apps for a lack of interactivity, openness or user control, saying,"the biggest flaw for me is the total lack of acknowledgment that the device this content appears on is part of the Internet, and therefore it is possible to connect the content to other places with more information about a topic."But some news organizations are already busy preparing for the next big thing: According to The Wall Street Journal, some national news orgs have begun developing content for Samsung's new tablet, the Galaxy, which is scheduled to be released later this year.
—
Too much of a good story?: Regardless of where you were this week, the huge story was the rescue of 33 Chilean miners who had been trapped underground for more than two months. The fact that it was such an all-encompassing story is, of course, a media story in itself: TV broadcasters planned wall-to-wall coverage beforehand, Herbal Glucophage, and that coverage garnered massive ratings in the U.S. and elsewhere. (We followed on the web, too.) With 2,000 journalists at the site, the event became a global media spectacle the likes of which we haven't seen in a while.
The coverage had plenty of critics, many of them upset about the excessive amount of resources devoted to a story with little long-term impact by news organizations that are making significant cuts to coverage elsewhere, Glucophage Mg. The point couldn't have been finer in the case of the BBC, comprar en línea Glucophage, comprar Glucophage baratos, which spent more than £100,000 on its rescue coverage, leading it to slash the budget for upcoming stories like the Cancun climate change meetings and Lisbon NATO summit.
The sharpest barbs belonged to NYU prof Jay Rosen and Lehigh prof Jeremy Littau. "The proportion of response to story impact is perhaps the best illustration of the insanity we seen in media business choices today," Littau wrote, Buy Glucophage without a prescription, adding,"I see an industry chasing hits and page views by wasting valuable economic and human capital." Lost Remote's Steve Safran pointed out that the degree of coverage had much more to do with the fact that coverage could be planned than with its newsworthiness.
—
Rupert keeps pushing into paywalls: After his Times and Sunday Times went behind a paywall this summer, Rupert Murdoch added another newspaper to his online paid-content empire this week: The British tabloid News of the World. Access to the paper's site will cost a pound a day or £1.99 for four weeks, and will include some web exclusives, including a new video section, no prescription Glucophage online. PaidContent gave the new site itself a good review Glucophage Mg, , saying it's an improvement over the old one.
The business plan behind the paywall didn't get such kind reviews. As with The Times' paywall, News of the World's content will be hidden from Google and other search engines, and while paidContent reported that its videos had been reposted on YouTube before the site even launched, the paper's digital editor told Journalism.co.uk that it's working aggressively to keep its content within the site, Glucophage wiki, including calling in the lawyers if need be. The Press Gazette's Dominic Ponsford argued that the new site formally marks Murdoch's retreat from the web: "Without any inbound or outbound links, and invisible to Google and other search engines, the NotW, Times and Sunday Times don’t really have internet sites – but digitally delivered editions."British journalist Kevin Anderson was a little more charitable, saying the strategy just might be an early step toward a frictionless all-app approach to digital news.
As for Murdoch's other paywall experiment at The Times, Glucophage class, two editors gave a recent talk (reported by Editors Weblog) that juxtaposed two interesting ideas: The editors claimed that a subscription-based website makes them more focused on the user, then touted this as an advantage of the iPad: "People consume how you want them to consume."
—
News orgs' kibosh on political participation: NPR created a bit of buzz this week when it sent a memo to employees explaining that they were not allowed to attend the upcoming rallies by comedians Jon Stewart and Stephen Colbert (unless they were covering the events), as they constitute unethical participation in a political rally. The rule forbidding journalists to participate in political rallies is an old one in newsrooms, and at least eight of the U.S.' largest news organizations told The Huffington Post their journalists also wouldn't be attending the rallies outside of work, Glucophage Mg.
NPR senior VP Dana Davis Rehm explained in a post on its site that NPR issued the memo to clear up any confusion about whether the rallies, which are at least partly satirical in nature, About Glucophage, were in fact political. NPR's fresh implementation prompted a new round of criticism of the longstanding rule, especially from those skeptical of efforts at "objective" journalism: The Wrap's Dylan Stableford called it "insane," Northeastern j-prof Dan Kennedy said the prohibition keeps journalists from observing and learning, and CUNY j-prof Jeff Jarvis made a similar point, arguing that "NPR is forbidding its employees to be curious."
—
A closer look at Denton and Huffington: In the past week, we've gotten long profiles of two new media magnates in a New Yorker piece on Gawker chief Nick Denton and a Forbes story on Arianna Huffington and her Huffington Post, Glucophage no rx. (Huffington also gave a good Q&A to Investor's Business Daily.) Reaction to the Denton articles was pretty subdued, but former Gawker editor Elizabeth Spiers (who wrote the Huffington piece) had some interesting thoughts about how Gawker has become part of the mainstream, though not everyone agrees whether its success is replicable.
Figures in the pieces prompted Reuters' Felix Salmon and Forbes' Jeff Bercovici to break down the sites' valuation. Glucophage Mg, (Salmon only looks at Gawker, though Bercovici compares the two in traffic value and in their owners' roles.) The two networks have long been rivals, and Denton noted that thanks to a couple of big sports-related scandals, Gawker's traffic beat the Post's for the first time ever this week. Also this week, Rx free Glucophage, Huffington announced she'd pay $250,000 to send buses to Jon Stewart's rally later this month, an idea the Wrap said some of her employees weren't crazy about.
—
Reading roundup: Busy, busy week this week. We'll see how much good stuff I can point you toward before your eyes start glazing over.
— A few follow-ups to last week's discussion of Howard Kurtz's move from The Washington Post to The Daily Beast: The New York Times' David Carr wrote a lyrical column comparing writing for print and for the web, Glucophage samples, PBS MediaShift's Mark Glaser interviewed Kurtzon Twitter, and former ESPN.com writer Dan Shanoff pointed out that the move from mainstream media to the web began in the sports world.
— An update on the debate over content farms: MediaWeek ran an article explaining why advertisers like them so much; one of those content farms, Demand Media said in an SEC filing that it plans to spend $50 million to $75 million on investments in content next year; and one hyperlocal operation accused of running on a content-farm model, AOL's Patch, responded to its critics' allegations, Glucophage Mg.
— Two interesting discussions between The Guardian and Jeff Jarvis: Guardian editor Alan Rusbridger posted some thoughts about his concept of the Fourth Estate — the traditional press, public media, and the web's public sphere — and Jarvis responded by calling the classification "correct but temporary." The Guardian's Roy Greenslade also wrote about his concern for the news/advertising divide as journalists become entrepreneurs, Glucophage dose, and Jarvis, an entrepreneurial journalism advocate, defended his cause.
— Three other good reads before we're done:
GigaOM's Mathew Ingram told newspapers it's better to join Groupon than to fight it.
Newspaper analyst Alan Mutter laid out French research that illuminates just how far digital natives' values are from those of the newspaper industry — and what a hurdle those newspapers have in reaching those consumers.
Scott Rosenberg looked at the closed systems encroaching on the web and asked a thought-provoking question: Is the openness that has defined the web destined to be just a parenthesis in a longer history of control. It's a big question and, as Rosenberg reminds us, a critical one for the future of news.
Similar posts: Purchase Flagyl. Buy Bactrim No Prescription. Zoloft No Rx. About Glucophage. Where can i order Glucophage without prescription. Cipro brand name.
Trackbacks from: Glucophage Mg. Glucophage Mg. Glucophage Mg. Glucophage dangers. Order Glucophage from United States pharmacy. Glucophage used for.